10|2025
Proven Effectiveness: NeuroStar® Advanced Therapy has delivered over 7.1 million treatments, benefiting over 195,000 patients across more than 1,100 practices in the U.S. It is recognized as the market leader in clinical practice for depression treatment. Long-Term Efficacy: NeuroStar has demonstrated long-term effectiveness with established durability for up to 12 months post-treatment. This indicates sustained… Read more »
10|2025
Main Findings from the Data Presented at the 2024 AACAP Annual Conference on NeuroStar® TMS for Adolescents: 1. High Remission and Response Rates: – Nearly 60% of adolescents aged 12-19 with Major Depressive Disorder (MDD) achieved remission after treatment with NeuroStar Advanced TMS. – The remission rate for young adults aged 20-21 was… Read more »
05|2025
Supporting the Brain to Function Properly 1. High Response Rate: A real-world study reported an 83% response rate among patients who completed their NeuroStar treatment cycle, meaning they saw measurable improvements in their depression symptoms. 2. Significant Remission: The same study showed a 62% remission rate, indicating that 62% of patients who completed the treatment… Read more »
04|2024
Physicians use the word “trauma” to describe a serious injury to the physical body resulting from a sudden impact, such as an accident or a violent act. But you can also suffer emotional trauma, which can cause an equally painful wound to your sense of self as a whole, coherent being. Just like a wound… Read more »
10|2022
From Hopelessness to Happiness—a Learnable Life Skill If life could be graded, Anthony would give his an “F” with not much optimism for the future. His new job is stressful, his teenage daughter is struggling with depression, he and his wife are fighting a lot lately, and he hates himself for the extra 50 pounds… Read more »
